Growth Metrics

Vericel (VCEL) EBITDA (2016 - 2025)

Historic EBITDA for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to $3.4 million.

  • Vericel's EBITDA rose 23995.94% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 67835.64%. This contributed to the annual value of $4.5 million for FY2024, which is 16991.03% up from last year.
  • According to the latest figures from Q3 2025, Vericel's EBITDA is $3.4 million, which was up 23995.94% from -$2.0 million recorded in Q2 2025.
  • Over the past 5 years, Vericel's EBITDA peaked at $18.5 million during Q4 2024, and registered a low of -$12.8 million during Q1 2025.
  • Its 5-year average for EBITDA is -$2.0 million, with a median of -$5.0 million in 2021.
  • As far as peak fluctuations go, Vericel's EBITDA tumbled by 24105.77% in 2021, and later surged by 23995.94% in 2025.
  • Over the past 5 years, Vericel's EBITDA (Quarter) stood at $4.1 million in 2021, then surged by 46.95% to $6.1 million in 2022, then skyrocketed by 109.22% to $12.7 million in 2023, then soared by 45.15% to $18.5 million in 2024, then crashed by 81.33% to $3.4 million in 2025.
  • Its EBITDA stands at $3.4 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$12.8 million for Q1 2025.